ArticleScientific reports2022

BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia.

Khashayar Roohollahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.